The demand for plant derived analgesics in japan is projected to grow from USD 215.9 million in 2025 to USD 365.3 million by 2035, at a CAGR of 5.4%. Morphine will dominate with a 31.0% market share, while tablets will lead the formulation type segment with a 40.4% share.